Impact of Vaccination in Acute COVID-19
Completed
- Conditions
- COVID-19
- Interventions
- Biological: vaccination
- Registration Number
- NCT05198453
- Lead Sponsor
- University Medical Centre Ljubljana
- Brief Summary
The aim of this study was to evaluate the association between vaccination with one of the four SARS-CoV-2 vaccines authorized for use in the European Union-BNT162b2, ChAdOx-1S, mRNA-1273 or Ad.26.COV2.S-and progression to critically severe disease among adult patients with PCR-confirmed acute COVID-19.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 529
Inclusion Criteria
- age 18 yers or more
- hospitalized for acute COVID-19
- PCR confirmed infection with SARS-CoV-2
Exclusion Criteria
- hospitalized for other conditions
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Arm && Interventions
Group Intervention Description vaccinated patients with COVID-19 vaccination -
- Primary Outcome Measures
Name Time Method number (%) with critically severe disease assessment performed at a minimum 30 days after admission
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (1)
University Medical Center Ljubljana
🇸🇮Ljubljana, Slovenia